How do short‐term practice effects compare to biomarkers of Alzheimer’s disease?
Kevin Duff, Dustin B Hammers, Vincent Koppelmans, Jace B King, John M Hoffman · 2025
Read How do short‐term practice effects compare to biomarkers of Alzheimer’s disease? by Kevin Duff, Dustin B Hammers, Vincent Koppelmans, Jace B King, John M Hoffman (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11710530.txt.
Description
Kevin Duff and co-authors ask whether how much people improve on a repeated thinking test can rival lab markers of Alzheimer's disease. Practice gains are a simple signal: healthy brains learn the test, fading brains less so. The signal is cheap, yet it is rarely set beside costly scans and blood markers.
Three groups took a short test battery twice, one week apart: 68 healthy older adults, 52 with mild memory loss, and 45 with mild Alzheimer's. All also had brain scans for the disease's marker protein and a gene risk check. Healthy adults gained most from practice, the mild group less, and the Alzheimer's group least. Protein load split the healthy group from the other two. A humble retest score may earn a place beside high-tech markers.
Catalog record
| CREATOR | Kevin Duff, Dustin B Hammers, Vincent Koppelmans, Jace B King, John M Hoffman |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 3 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |